Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145950

Pw145950 View Pathway
drug action

Trimetazidine Drug Metabolism Action Pathway

Homo sapiens

PW127933

Pw127933 View Pathway
drug action

Trimethadione Action Pathway

Homo sapiens
Trimethadione is an anticonvulsant agent indicated for the control of treatment-refractory petit mal seizures. An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. Paramethadione and trimethadione are anticonvulsants indicated in the control of absence (petit mal) seizures that are refractory to treatment with other medications. Dione anticonvulsants are used in the treatment of epilepsy. They act on the central nervous system (CNS) to reduce the number of seizures. Dione anticonvulsants reduce T-type calcium currents in thalamic neurons, including thalamic relay neurons. It does so via the inhibition of voltage dependent T-type calcium channels. This raises the threshold for repetitive activity in the thalamus, and inhibits corticothalamic transmission. Thus, the abnormal thalamocortical rhythmicity, which is thought to underlie the 3-Hz spike-and-wave discharge seen on electroencephalogram(EEG) with absence seizures, is dampened. GABA release is inhibited due to mutations of the SCN1A, SCN1B gene causing enhanced reuptake. Possible side effects of using trimethadione may include tiredness, changes in weight, hiccups, and headache.

PW144473

Pw144473 View Pathway
drug action

Trimethadione Drug Metabolism Action Pathway

Homo sapiens

PW176157

Pw176157 View Pathway
metabolic

Trimethadione Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Trimethadione are predicted with biotransformer.

PW145205

Pw145205 View Pathway
drug action

Trimethaphan Drug Metabolism Action Pathway

Homo sapiens

PW144775

Pw144775 View Pathway
drug action

Trimethobenzamide Drug Metabolism Action Pathway

Homo sapiens

PW144565

Pw144565 View Pathway
drug action

Trimethoprim Drug Metabolism Action Pathway

Homo sapiens

PW176444

Pw176444 View Pathway
metabolic

Trimethoprim Predicted Metabolism Pathway

Homo sapiens
Metabolites of Trimethoprim are predicted with biotransformer.

PW145245

Pw145245 View Pathway
drug action

Trimetrexate Drug Metabolism Action Pathway

Homo sapiens

PW127943

Pw127943 View Pathway
drug action

Trimipramine Action Pathway

Homo sapiens
Trimipramine is a tricyclic antidepressant (TCA) used to treat depression accompanied or not by anxiety and agitation or sleep disturbance. It is very similar to imipramine but it has more antihistaminic and sedative properties. Trimipramine acts by decreasing the reuptake of norepinephrine and serotonin (5-HT) in the neurons. By binding to the sodium-dependent serotonin transporter and the sodium-dependent noradrenaline transporter, trimipramine fulfill its functions. Some side effects of its use include agitation, convulsions, irregular heart rate, muscle rigidity, stupor, and some others. This drug is administered as an oral tablet.